Healthy Life Agritec Limited reports FY26 revenue of ₹228.14 crore
Key highlights
- Healthy Life Agritec Limited reported FY26 revenue of ₹228.14 crore, up 32.74% from ₹171.87 crore in FY25.
- FY26 operating profit rose 24.60% to ₹5.42 crore, while net profit increased 22.70% to ₹4.00 crore.
- The June 2026 quarterly table reported total income of ₹69.52 crore and profit after tax of ₹1.39 crore.
- Healthy Life Agritec's BSE price was ₹5.00 on November 20, 2026, unchanged from the previous close.
powered by IRIS

Healthy Life Agritec Limited reported FY26 revenue of ₹228.14 crore, a 32.74% increase from ₹171.87 crore in FY25, while the company appears in the results calendar dated November 21, 2026. The available data also shows that investors need to distinguish between annual figures, quarterly tables and separately displayed Q2 FY27 information.
Know Healthy Life Agritec inside out
Results, valuation, peers and who's buying, in one view.
What did Healthy Life Agritec Limited report for FY26?
Healthy Life Agritec Limited reported revenue of ₹228.14 crore for FY26, compared with ₹171.87 crore in FY25. The company’s operating profit rose to ₹5.42 crore from ₹4.35 crore, while net profit increased to ₹4.00 crore from ₹3.26 crore.
The reported annual revenue growth was 32.74%, operating-profit growth was 24.60%, and net-profit growth was 22.70%. Revenue therefore grew faster than operating profit and net profit on the figures provided. The data does not provide management commentary on the causes of the yearly increase, business segments, product demand or changes in costs.
The annual information is important because it supplies the clearest comparable full-year view in the available material. It also provides a broader context for evaluating the company’s more volatile quarterly numbers, which moved substantially over the periods displayed.
How did Healthy Life Agritec perform in the June 2026 quarter?
Healthy Life Agritec reported total income of ₹69.52 crore and profit after tax of ₹1.39 crore for the June 2026 quarter in the quarterly financial table. Total income was down 18.39% from ₹85.19 crore in March 2026, whereas profit after tax rose 32.86% from ₹1.05 crore.
The same quarterly table listed EBIT at ₹2.16 crore, against ₹1.83 crore in the preceding quarter. EBIT margin improved to 3.11% from 2.15%, and net profit margin increased to 2.01% from 1.23%. Basic earnings per share in that table were ₹0.28 for June 2026.
A separately provided quarterly-results summary showed operating profit of ₹1.89 crore for June 2026, up from ₹1.48 crore in March, and EPS of ₹0.81. Another historical financial table showed operating profit of ₹2.27 crore and EPS of ₹0.28 for June. These differences mean that the data extracts may be using different financial statements, classifications or sources. The supplied material does not provide enough detail to reconcile them.
What does the available Q2 FY27 information show?
The available Q2 FY27 listing shows revenue of ₹28 crore, down 45.27% quarter on quarter and up 70.37% year on year, with net profit displayed as ₹0 crore. It identifies November 14, 2026 as the last earnings date for Q2 FY26-27, although the associated figures are presented without decimal precision.
This Q2 FY27 snapshot differs sharply from the June 2026 financial tables and should not be treated as directly comparable without checking the underlying exchange filing. In particular, the supplied material does not state whether the ₹28 crore figure is standalone or consolidated, nor does it specify the exact profit figure behind the rounded display of ₹0 crore.
The results-calendar information also lists board meetings for quarterly results on November 13 and November 20, 2026. The company was included in a results calendar dated November 21, 2026. However, the provided text does not include a complete, board-approved Q2 FY27 financial statement with a full income statement, balance sheet or notes to accounts.
Got a follow-up? Ask IRIS
Why should investors check the underlying filing?
Investors should check the underlying filing because the supplied information contains multiple figures for the June 2026 quarter and limited detail for Q2 FY27. A filing on the stock exchange can clarify whether numbers are standalone or consolidated, whether they are audited or unaudited, and the accounting basis used for revenue, operating profit and earnings per share.
The company had earlier said that submission of its financial results for the quarter and year ended March 31 was delayed because subsidiary financials were received late. According to the company update, the board meeting to approve those results was rescheduled twice before the financials were considered and approved. Healthy Life Agritec described the delay as unintentional and said it remained committed to timely compliance.
The material also states that a September 29, 2026 board meeting was postponed until stock-exchange approval for a rights issue. A September 22 board meeting was listed for a fund-raising proposal. These corporate actions are separate from operating results, but they are relevant to shareholders because financing activity and compliance updates can affect the information investors seek alongside earnings.
How has the market data reflected the reported developments?
The latest quoted price for Healthy Life Agritec was ₹5.00 on the BSE at 3:08 PM IST on November 20, 2026, unchanged from the previous trading day’s closing price. The supplied material provides no percentage return over a longer period, trading volume, market capitalisation or broker assessment, so no broader conclusion on market reaction can be drawn from the available data.
For investors, the key reported financial trend is that FY26 revenue, operating profit and net profit were all higher than FY25. At the same time, quarterly income declined from March to June 2026 while profit after tax improved in the displayed table. The incomplete and inconsistent Q2 FY27 extracts make the formal result filing, including its standalone or consolidated status, particularly important for interpreting the next reported period.
Conclusion
Healthy Life Agritec’s reported FY26 figures show revenue of ₹228.14 crore, operating profit of ₹5.42 crore and net profit of ₹4.00 crore, all above FY25 levels. June 2026 quarterly data showed lower income than March but higher reported profit after tax, while the supplied Q2 FY27 snapshot showed ₹28 crore of revenue and a rounded net-profit display of ₹0 crore.
The next item to watch is the complete quarterly result disclosure associated with the November 2026 board-meeting dates, including the financial-statement basis and detailed notes. Investors may also monitor developments relating to the proposed rights issue and fund-raising process referred to in the company’s corporate-action history.


